## Assessment of Glycemic Control Failure **Key Point:** This patient has failed lifestyle intervention. Her fasting glucose (105–110 mg/dL) and 2-hour postprandial values (155–165 mg/dL) exceed targets despite 2 weeks of optimal dietary management and SMBG. The next step is pharmacotherapy. ## Glycemic Targets in GDM (Reminder) | Parameter | Target (mg/dL) | Patient's Value (mg/dL) | Status | | --- | --- | --- | --- | | Fasting | <95 | 105–110 | **Above target** | | 2-hour postprandial | <120 | 155–165 | **Above target** | ## Choice of First-Line Pharmacotherapy in GDM **High-Yield:** In India and most international guidelines, **insulin is the preferred first-line pharmacotherapy for GDM** because: 1. Insulin does not cross the placenta (safe for fetus). 2. Rapid glycemic control is achievable (critical in pregnancy). 3. Extensive safety data in pregnancy. 4. No teratogenic risk. Metformin is an alternative (especially in obese GDM or PCOS-related GDM), but insulin is preferred as first-line in most cases, particularly when fasting hyperglycemia is present. **Clinical Pearl:** Fasting hyperglycemia (>95 mg/dL) in GDM typically reflects impaired hepatic glucose production and is best controlled with **basal insulin (NPH or long-acting insulin)**. Postprandial hyperglycemia may require rapid-acting insulin with meals. ## Insulin Initiation Strategy in GDM ```mermaid flowchart TD A[GDM with Failed Lifestyle Intervention]:::outcome --> B{Pattern of Hyperglycemia?}:::decision B -->|Fasting + Postprandial| C[Start Basal Insulin + Meal Insulin]:::action B -->|Fasting only| D[Start NPH at Bedtime]:::action B -->|Postprandial only| E[Start Rapid-Acting Insulin with Meals]:::action D --> F[Titrate by 2-4 units every 3-4 days]:::action E --> F C --> F F --> G[Target: Fasting <95, Postprandial <120 mg/dL]:::action G --> H[Continue until delivery]:::action ``` **Tip:** NPH insulin 10 units at bedtime is a reasonable starting dose for fasting hyperglycemia. Titration is performed by 2–4 units every 3–4 days based on fasting glucose readings. Rapid-acting insulin (aspart, lispro) is added if postprandial targets are not met.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.